Trial Profile
Effect of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy (SBMA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2011
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications X-linked bulbo-spinal atrophy
- Focus Therapeutic Use
- 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 14 Apr 2011 New trial record